“Strat-Marker Discovery & Expanded Access Programs”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya Smale

Jess Rabourn of AX-S Pharma  joined us for World Orphan Drug Congress USA 2015 to present about ‘Strat-Marker Discovery & Expanded Access Programs’. 
Download the presentation now to learn more about:

  • Clinical development failure in poorly understood diseases
  • Biomarkers to target therapy
  • Stratification Factors
  • Leveraging Trial Data for Custom (Personalized) Stratification markers
…and much more!
Get your copy here
To find out more about  strat-marker discovery , join us at  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.